Produktname:2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid
IUPAC Name:2-(5-methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid
Product Overview |
2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid (2-MOPAA) is a derivative of the pyridazinone family of compounds. It is a small molecule that has a variety of biological activities and has been studied for its potential in treating a variety of diseases. |
Physical Properties |
It is not very water soluble, which can make it difficult to dissolve and use in experiments. |
Chemical Properties |
It is a small molecule, which makes it easy to synthesize and manipulate in the laboratory. It has been found to have a relatively short half-life, which can make it difficult to study its effects over a prolonged period of time. |
Synthesis and Application |
It has been found to have anti-inflammatory properties and has been studied for its potential to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. It has also been studied for its potential to act as an anti-cancer agent and has been found to have anti-tumor activity in several cancer cell lines. It has also been studied for its potential to act as an anti-oxidant and to modulate the activity of several proteins. |
Future Directions |
These include further studying its anti-inflammatory, anti-cancer, and anti-oxidant properties. Additionally, further studies can be done to explore its potential to act as an enzyme inhibitor and to modulate the activity of several proteins. Additionally, further research can be done to explore the potential of 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid as an anti-viral agent. Finally, further research can be done to explore the potential of 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid as a drug delivery agent, as it has been found to have a relatively short half-life. |